Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease
Top Cited Papers
- 4 March 2005
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 32 (4) , 486-510
- https://doi.org/10.1007/s00259-005-1762-7
Abstract
The demographics of aging suggest a great need for the early diagnosis of dementia and the development of preventive strategies. Neuropathology and structural MRI studies have pointed to the medial temporal lobe (MTL) as the brain region earliest affected in Alzheimer’s disease (AD). MRI findings provide strong evidence that in mild cognitive impairments (MCI), AD-related volume losses can be reproducibly detected in the hippocampus, the entorhinal cortex (EC) and, to a lesser extent, the parahippocampal gyrus; they also indicate that lateral temporal lobe changes are becoming increasingly useful in predicting the transition to dementia. Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) imaging has revealed glucose metabolic reductions in the parieto-temporal, frontal and posterior cingulate cortices to be the hallmark of AD. Overall, the pattern of cortical metabolic changes has been useful for the prediction of future AD as well as in distinguishing AD from other neurodegenerative diseases. FDG-PET on average achieves 90% sensitivity in identifying AD, although specificity in differentiating AD from other dementias is lower. Moreover, recent MRI-guided FDG-PET studies have shown that MTL hypometabolism is the most specific and sensitive measure for the identification of MCI, while the utility of cortical deficits is controversial. This review highlights cross-sectional, prediction and longitudinal FDG-PET studies and attempts to put into perspective the value of FDG-PET in diagnosing AD-like changes, particularly at an early stage, and in providing diagnostic specificity. The examination of MTL structures, which has so far been exclusive to MRI protocols, is then examined as a possible strategy to improve diagnostic specificity. All told, there is considerable promise that early and specific diagnosis is feasible through a combination of imaging modalities.Keywords
This publication has 187 references indexed in Scilit:
- Limbic hypometabolism in Alzheimer's disease and mild cognitive impairmentAnnals of Neurology, 2003
- PET studies in dementiaAnnals of Nuclear Medicine, 2003
- Normal and pathological aging - findings of positron-emission-tomographyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Age-Associated Memory Loss: Initial Neuropsychological and Cerebral Metabolic Findings of a Longitudinal StudyInternational Psychogeriatrics, 1994
- MR‐based hippocampal volumetry in the diagnosis of Alzheimer's diseaseNeurology, 1992
- B- Amyloid increases neuronal susceptibility to injufy by glucose deprivationNeuroReport, 1991
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer typeJournal of Clinical and Experimental Neuropsychology, 1988
- Epidemiology of Alzheimer's disease and other dementing illnessesJournal of Chronic Diseases, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984